Basic Information
ID: ALA4403842
Type: ADME
Description: Drug metabolism in human liver S9 fractions assessed as assessed as NAT-mediated phase 2 metabolism at 1 mM preincubated for 5 mins followed by NADPH addition and measured after 60 mins by RP-UHPLC-DAD analysis relative to control
Format: BAO_0000220
Organism: Homo sapiens
Tissue: Liver
Subcellular Fraction: S9
Target: Unchecked(ALA612545)
Document: ALA4402547
Drug metabolism in human liver S9 fractions assessed as assessed as NAT-mediated phase 2 metabolism at 1 mM preincubated for 5 mins followed by NADPH addition and measured after 60 mins by RP-UHPLC-DAD analysis relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4403842
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 303.34 | 3.59 | 3.59 |
| 388.43 | 6.08 | 6.08 |